Table 3.
BPN pharmacological interactions
Drug | Effect | Management |
---|---|---|
Severe interactions | ||
Benzondiazepines, muscle relaxants, anesthetics, antipsychotics, alcohol and opioids | Increases the risk of BPN overdose, hypotension, respiratory depression, coma, and death Alters the usual ceiling effect on respiratory depression induced by BPN Precipitation of withdrawal symptoms and/or decrease in the analgesic effect of BPN after combination with mixed agonist opioids or antagonists |
Coadministration of these drugs should be avoided Extreme patient vigilance is required if concomitant use with CNS depressants is necessary85–88 |
Pregabalin | Increases the risk of BPN overdose, hypotension, respiratory depression, coma, and death. Alters the usual ceiling effect on respiratory depression induced by BPN | Coadministration with BPN should be avoided89 |
Escitalopram | Increases the risk of a life-threatening irregular heart rhythm | Caution is advised90 |
Moderate interactions | ||
Albuterol | Increases the risk of an irregular heart rhythm, which can be serious and fatal; however, this is a rare side effect | Avoid concomitant use91 |
Duloxetine | Dizziness, drowsiness, confusion, and difficulty in concentrating | Coadministration should be avoided92 |
Fluoxetine | Dizziness, drowsiness, confusion, and difficulty in concentrating. Norfluoxetine (active metabolite) inhibits BPN dealkylation |
During concomitant use, dosage adjustment may be necessary92,93 |
Quetiapine | Increases the risk of an irregular heart rhythm, which can be serious and life threatening, but is rare | Caution and clinical monitoring if concomitant use is required94,95 |
Laxatives (Senna) | Irregular heartbeat, which can be severe and life threatening, but is rare | Caution in coadministration96 |
Abbreviations: BPN, buprenorphine; CNS, central nervous system.